UA89397C2 - Средство для профилактики или лечения депрессивных или тревожных расстройств - Google Patents

Средство для профилактики или лечения депрессивных или тревожных расстройств

Info

Publication number
UA89397C2
UA89397C2 UAA200710985A UAA200710985A UA89397C2 UA 89397 C2 UA89397 C2 UA 89397C2 UA A200710985 A UAA200710985 A UA A200710985A UA A200710985 A UAA200710985 A UA A200710985A UA 89397 C2 UA89397 C2 UA 89397C2
Authority
UA
Ukraine
Prior art keywords
remedy
preventive
depression
anxiety neurosis
neurosis
Prior art date
Application number
UAA200710985A
Other languages
English (en)
Ukrainian (uk)
Inventor
Кейсуке Хираи
Масаоми Миямото
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37073564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA89397(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of UA89397C2 publication Critical patent/UA89397C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA200710985A 2005-04-04 2006-04-03 Средство для профилактики или лечения депрессивных или тревожных расстройств UA89397C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005107674 2005-04-04

Publications (1)

Publication Number Publication Date
UA89397C2 true UA89397C2 (ru) 2010-01-25

Family

ID=37073564

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710985A UA89397C2 (ru) 2005-04-04 2006-04-03 Средство для профилактики или лечения депрессивных или тревожных расстройств

Country Status (23)

Country Link
US (1) US20090042861A1 (ru)
EP (1) EP1867641A4 (ru)
JP (1) JP5259181B2 (ru)
KR (1) KR20070118103A (ru)
CN (1) CN101189219A (ru)
AR (1) AR054435A1 (ru)
AU (1) AU2006231752B2 (ru)
BR (1) BRPI0607684A2 (ru)
CA (1) CA2602267A1 (ru)
CL (1) CL2009000980A1 (ru)
CR (1) CR9385A (ru)
GE (1) GEP20105001B (ru)
IL (1) IL186049A0 (ru)
MA (1) MA29677B1 (ru)
MY (1) MY142214A (ru)
NO (1) NO20075599L (ru)
NZ (1) NZ561677A (ru)
PE (1) PE20061355A1 (ru)
RU (1) RU2413510C2 (ru)
TW (1) TWI391132B (ru)
UA (1) UA89397C2 (ru)
WO (1) WO2006107019A1 (ru)
ZA (1) ZA200708445B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2713598C (en) * 2008-01-31 2016-07-05 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP5600747B2 (ja) * 2011-01-17 2014-10-01 武田薬品工業株式会社 口腔内分散性製剤
EP2765985A1 (en) * 2011-10-14 2014-08-20 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
RU2571546C1 (ru) * 2014-07-14 2015-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ дифференцированной диагностики и терапии синдрома ночной еды
US20200022951A1 (en) 2017-03-30 2020-01-23 Jose Eduardo PENELLO TEMPORÃO Multivitamin composition for improving verbal fluency, decreasing performance anxiety symptoms and method for preparing same
CN108451917A (zh) * 2018-03-22 2018-08-28 仁和堂药业有限公司 高稳定性米安色林制剂的制备方法
CN113908165A (zh) * 2020-07-10 2022-01-11 上海日馨医药科技股份有限公司 一种药物组合物及其应用
WO2025018810A1 (ko) * 2023-07-18 2025-01-23 주식회사 지오비스타 동물에 대한 정신질환 또는 행동장애의 예방 또는 치료용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham P.L.C., Brentford Benzopyrans und deren verwendung als therapeutische mittel
US5780470A (en) * 1995-06-02 1998-07-14 Bristol-Myers Squibb Company Melatonergic indanyl piperazines
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
WO1997032871A1 (en) * 1996-03-08 1997-09-12 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
US6348485B1 (en) * 1998-06-09 2002-02-19 Takeda Chemical Industries, Ltd. Method for treating or preventing sleep disorders
JP3509637B2 (ja) * 1998-06-09 2004-03-22 武田薬品工業株式会社 睡眠障害予防治療剤
BR0111976A (pt) * 2000-06-27 2003-12-09 Taisho Pharmaceutical Co Ltd Preparação terapêutica para neurose ou depressão por ansiedade, e, derivado de piperazina
US6589978B2 (en) * 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
EP1425017A1 (en) * 2001-09-13 2004-06-09 Schering Corporation Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder

Also Published As

Publication number Publication date
JPWO2006107019A1 (ja) 2008-09-25
ZA200708445B (en) 2009-03-25
CN101189219A (zh) 2008-05-28
JP5259181B2 (ja) 2013-08-07
EP1867641A4 (en) 2010-01-13
US20090042861A1 (en) 2009-02-12
TWI391132B (zh) 2013-04-01
MA29677B1 (fr) 2008-08-01
AR054435A1 (es) 2007-06-27
WO2006107019A1 (ja) 2006-10-12
KR20070118103A (ko) 2007-12-13
CR9385A (es) 2007-12-07
NO20075599L (no) 2007-12-19
TW200719885A (en) 2007-06-01
NZ561677A (en) 2011-02-25
AU2006231752B2 (en) 2012-03-01
IL186049A0 (en) 2008-02-09
EP1867641A1 (en) 2007-12-19
AU2006231752A1 (en) 2006-10-12
CA2602267A1 (en) 2006-10-12
GEP20105001B (en) 2010-06-10
RU2413510C2 (ru) 2011-03-10
RU2007140986A (ru) 2009-05-20
MY142214A (en) 2010-11-15
PE20061355A1 (es) 2007-01-15
CL2009000980A1 (es) 2009-08-14
BRPI0607684A2 (pt) 2009-09-22

Similar Documents

Publication Publication Date Title
DE502004003249D1 (en) (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum
EA200801959A1 (ru) Высокоразветвленный полипропилен
MX2010002692A (es) Sintesis de catecoles deuterados y derivados de benzo[d][1,3]dioxoles de los mismos.
MX2009007077A (es) Analogos de ciclopamina.
KR101434673B9 (ko) 할리콘드린 ｂ 유사체의 제조를 위한 중간체
CR9385A (es) Agente preventivo o terapeutico para el desorden de la depresion o la ansiedad
SG152188A1 (en) Crown for timepiece
ZA200604114B (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
IL183061A0 (en) Aryloxyethylamine derivatives with a combination of partial dopamine d2 receptor agonism and serotonin reuptake inhibition
MX2009006337A (es) Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
MY148459A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
MY147271A (en) Accelerating agent of calcium absorption
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
TW200728310A (en) Process for the preparation of ferri-succinylcasein
MX2007012219A (es) Medida de prevencion o remedio para neurosis paro depresion o ansiedad.
WO2010041271A3 (en) Process for preparation of (s)-n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4-b]furan-8-yl)ethyl] propionamide and novel intermediates thereof
ATE551036T1 (de) Kondomverpackung
UY32479A (es) Procedimiento para la preparación de ramelteon
MY148806A (en) Prophylactic or therapeutic agent for nocturnal conduct disorder associated with dementia
ZA200902732B (en) Method for the synthesis of n-[3-(2-methoxyphenyl)sulfanyl]-2-methoylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine
NO20073390L (no) Fenylpiperaziner med en kombinasjon av affinitet for dopamin-D2-reseptorer og serotoningjenopptaksseter
HRPK20070517B3 (en) Escitalopram hydrobromide and a method for the preparation thereof
AU2006904356A0 (en) "Improved scotch yoke fluid machine"
DE202005000302U1 (de) Jacke mit integrierter Schwimmweste